Translational Pathways for Cardiovascular Devices – Session III: Challenges of Tricuspid Valve Interventions From the Regulatory Perspective – Changfu Wu Practice Quiz

The comparator for new devices in trial design for repair of tricuspid regurgitation include all of the following, except:

A device that repairs the tricuspid valve and showed improvement in quality of life only, with no benefit of mortality, will not be approved by the regulatory authority

Standalone surgery for isolated tricuspid valve regurgitation is rarely performed